Theralase Technologies Inc (TLTFF)

[jedijazz]

Theralase currently generates $2 million in annual revenue from the laser therapy division of the company, and has a strategy in place to increase that figure by 300-400% in 2014. The growth strategy includes expansion across Canada and aggressively into major U.S. markets, as well as introducing a recurring revenue model with the release of the TLC-2000. The company has outsourced clinical studies to the University of Buffalo to demonstrate the efficacy of the new biofeedback technology. Theralase expects an installed base of 400 units at $16,500 each, which equates to $6.6 million in revenue.